Created through a partnership between the Newcastle Hospitals NHS Foundation Trust and Newcastle University and staffed by experts from each organisation, NewGene is the pioneer in developing, validating and delivering molecular diagnostics using the latest next generation sequencing and genotyping technologies.

The latest high throughput DNA sequencing technologies such as the Roche 454 GS-FLX, offer significant benefits to molecular diagnostics in terms of a high quality, fast turnaround and lower costs as compared to current establised technologies. Whilst these beneifts have been realised in the field of genomic research, there has been very little application in molecular diagnostics.

By deploying these technology platforms NewGene has the capability to handle large volumes of tests ensuring our clients benefit from the economies of scale through competitive pricing and fast turnarounds.

To date we have developed a range of tests for clinically significant inherited disorders and stratified medicine diagnostics for somatic mutations in cancers.  We deliver services to several UK National Health Service Trusts and overseas healthcare providers.  

NewGene is not just about the deployment of new technology, we pride ourselves in the provision of a service that integrates fully with our clients requirements. 

In addition to molecular diagnostics we also offer a fast turnaround and cost effective sequencing and genotyping service for researchers.

Click the links below to navigate to:-

• Molecular diagnostic services for inherited disorders.
• Personalised medicine services.
• Next generation sequencing and genotyping services for researchers.